Testing effectiveness (Phase 2)Ended earlyNCT00398047
What this trial is testing
Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes
Who this might be right for
LeukemiaMyelodysplastic Syndromes
Wake Forest University Health Sciences 3